US Markets
Home›US Markets›Equities›Travere Therapeutics stock tests another breakout abov…
Travere Therapeutics stock tests another breakout above $66
The stock was at $66.2 after rising 2.7% on the day, as it tried to clear a shelf buy point at 66.2.
Investors are watching Travere Therapeutics as the companys shares try to push through another breakout level near the $66 area, according to Yahoo Finance.
The stock was last shown at $66.18, up 2.7% on the day, and the page notes it is attempting to clear a shelf buy point at 66.2.
Yahoo Finance also highlighted that Travere Therapeutics has a 37% gain on the move, framing the latest price action as part of a broader effort to break higher from a key level.
← Newer storyCopper miners see breakout buy points as copper prices hold firmOlder story →AT&T set for potential location-data payout as Verizon loses appeal